This panel screens 23 genes associated with hereditary forms of prostate cancer. It is designed for men with a family history of prostate, breast, pancreatic, or ovarian cancer, which may indicate a shared genetic predisposition. Results from this test can help guide screening decisions, such as when to begin PSA monitoring or consider MRI screening. It also supports decision-making around treatment options for men with an existing diagnosis. Understanding genetic risk empowers individuals and their families to take proactive steps in cancer prevention and management.
Our Tests
NIPT (Non-Invasive Prenatal Test) Gender
NIPT Gender is the simplest version of the NonInvasive Prenatal Test (NIPT), designed for parents who primarily want to know their baby’s sex early in pregnancy.
NIPT (Non-Invasive Prenatal Test) Basic
NIPT Basic is the entrylevel NonInvasive Prenatal Test designed to screen for the most common chromosomal conditions in pregnancy.
NIPT (Non-Invasive Prenatal Test) Standard
NIPT Standard is a more comprehensive version of the NonInvasive Prenatal Test, designed for parents who want deeper insights into their baby’s chromosomal health.
NIPT (Non-Invasive Prenatal Test) Plus
NIPT Plus is an advanced version of the NonInvasive Prenatal Test (NIPT) designed to give expecting parents the most comprehensive view of their baby’s chromosomal health.
Comprehensive Hereditary Cancer Test (~300 genes)
Covers breast, ovarian, colorectal, prostate, pancreatic, gastric, melanoma, endocrine, and more.
Hereditary Breast and Ovarian Cancer Test (50 genes)
BRCA1/2 and related genes for breast and ovarian cancer risk.
Hereditary Prostate Cancer Test (23 genes)
Genes linked to inherited prostate cancer risk.
Hereditary Pancreatic Cancer Test (32 genes)
Genes associated with inherited pancreatic cancer risk.
Hereditary Colorectal Cancer Test (44 genes)
Genes for Lynch syndrome and other colorectal risks.